Dicerna pharmaceuticals ceo
WebFeb 28, 2024 · Dicerna Pharmaceuticals, Inc. (DRNA) Q4 2024 Earnings Conference Call February 27, 2024 4:30 PM ET Company Participants Lauren Stival – Stern Investor Relations, Inc. WebApr 4, 2024 · Aradhye, who is returning to Novartis, was most recently Executive Vice President and Chief Medical Officer at Dicerna Pharmaceuticals where he led the development of multiple clinical stage RNAi assets. ... CEO Novartis. “I would like to congratulate Marie-France, Shreeram, Steffen and Victor on their new roles, and extend …
Dicerna pharmaceuticals ceo
Did you know?
WebMay 15, 2024 · Dicerna Pharmaceuticals, Inc. (DRNA) Q1 2024 Earnings Conference Call May 14, 2024 4:30 PM ETExecutivesDouglas Fambrough - Co-Founder, CEO, … WebOct 29, 2024 · Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of innovative, subcutaneously delivered RNAi-based therapeutics for the treatment of …
WebApr 27, 2024 · Dicerna Pharmaceuticals’ board of directors last year doubled CEO Douglas Fambrough’s paycheck for the second time as the biotech continued its deal … WebAt Dicerna, we use RNA interference, or RNAi, to create medicines that silence or turn off the genes that cause or contribute to disease. Using our GalXC™ and GalXC-Plus™ technologies , we aim to develop safe, effective, specific and convenient RNAi therapies … At Dicerna, we are developing a pipeline of RNAi therapies designed to improve … Healthy mind and body. We believe progress starts with our people, so we’ll … Dicerna is developing belcesiran (DCR-A1AT) for the treatment of alpha-1 … We go right to the source. Genes play a primary role in thousands of diseases. … In October 2024, Dicerna entered into a research collaboration and licensing … Dicerna Pharmaceuticals. 75 Hayden Avenue Lexington, MA 02421. 33 … For delivering to tissues outside the liver, Dicerna continues to innovate using … At Dicerna, we are committed to working with patient communities to understand … At Dicerna Pharmaceuticals, we see drug development as a team endeavor. As … Dicerna provides opportunities for advocacy organizations and other non-profit …
WebOther. $8,451. Total Compensation. $2,547,018. CEO Pay Ratio. For its 2024 fiscal year, DICERNA PHARMACEUTICALS INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC. CEO Name. CEO Pay. WebSep 2, 2024 · President and CEO of Dicerna Pharmaceuticals Inc (30-Year Financial, Insider Trades) Douglas Fambrough (insider trades) bought 10,000 shares of DRNA on …
WebNov 18, 2024 · Dicerna Pharmaceuticals Inc., a Lexington-based firm focused on ribonucleic acid interference (RNAi) drugs, has agreed to be acquired by Denmark's Novo Nordisk A/S for $3.3 billion in cash.
WebFeb 26, 2024 · Dicerna Pharmaceuticals, Inc. (DRNA) Q4 2024 Earnings Conference Call February 25, 2024 4:30 PM ETCompany ParticipantsLauren Stival - Senior Director of IRDoug Fambrough - President and... chipotle in mckinney txWebDec 23, 2024 · Here is a summary of how the competitors of Dicerna Pharmaceuticals compare to one another: Alnylam Pharmaceuticals has the most employees (1,323). Employees at Rigel Pharmaceuticals earn more than most of the competitors, with an average yearly salary of $83,403. The oldest company is Rigel Pharmaceuticals, … chipotle in midland texasWebNov 18, 2024 · Dicerna Pharmaceuticals Inc., a Lexington-based firm focused on ribonucleic acid interference (RNAi) drugs, has agreed to be acquired by Denmark's … grant\u0027s oyster house sneads ferry ncWebDicerna is headquartered in Lexington, Massachusetts, the US. Headquarters United States of America. Address 75 Hayden Avenue, Lexington, Massachusetts, 02421. Website www.dicerna.com. Telephone 1 617 6218097. No of Employees 302. Industry Pharmaceuticals and Healthcare. Revenue (2024) $164.3M. grant\\u0027s oyster house sneads ferry ncWebAug 10, 2024 · The estimated net worth of Douglas Fambrough is at least $852,306.00 as of September 1st, 2024. Dr. Fambrough owns 22,300 shares of Dicerna Pharmaceuticals stock worth more than $852,306 as of April 10th. This net worth evaluation does not reflect any other assets that Dr. Fambrough may own. chipotle in mcdonough gaWebMay 28, 2024 · It would be hard to discount the role that CEO Douglas Fambrough has played in delivering the impressive results at Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) recently. Coming up to the next AGM ... chipotle in memphis tnWebJun 24, 2024 · The estimated Net Worth of Douglas Fambrough is at least $17.7 Million dollars as of 15 December 2024. Douglas Fambrough owns over 13,750 units of Dicerna Pharmaceuticals Inc stock worth over $9,049,693 and over the last 9 years he sold DRNA stock worth over $3,614,546. In addition, he makes $5,048,130 as President, Chief … grant\u0027s peace policy apush